Table 3. Antimicrobial activity measured by zone of inhibition of Shrishadi polyherbal drug (mm).

Microorganism	20 mg/mL	30 mg/mL	50 mg/mL	80 mg/mL	Standard drugs
Pseudomonas aeruginosa ATCC 27893	9.00±0.22	11.00±0.34	13.00±0.50	15.00±0.12	28 (Tobramycin)
Plesiomonas shigelloides ATCC 14029	10.00±0.11	11.00±0.09	12.00±0.31	18.00±0.22	26 (Tetracycline)
Salmonella typhi MTCC 3216	8.00±0.48	10.00±0.24	12.00±0.60	13.00±0.36	25 (Ciprofloxacin)
Escherichia coli ATCC 25922	7.00±0.18	9.00±0.26	10.00±0.31	12.00±0.35	26 (Norfloxacin)
Staphylococcus aureus ATCC 25323	10.00±0.49	11.00±0.51	12.00±0.37	14.00±0.35	24 (Ampicilin)
Shigella flexneri ATCC 12022	9.00±0.15	10.00±0.34	11.00±0.94	13.00±0.16	28 (Ciprofloxacin)
Candida albicans ATCC 90028	7.00±0.48	8.00±0.15	10.00±0.51	12.00±0.42	25 (Fluconazole)
Candida krusei ATCC 6258	8.00±0.90	9.00±0.23	11.00±0.46	13.00±0.34	16 (Amphotericin B)
Candida tropicalis ATCC 750	9.00±0.25	10.00±0.98	13.00±0.54	14.00±0.46	20 (Fluconazole)
Candida parapsilosis ATCC 22019	9.00±0.61	10.00±0.42	11.00±0.71	13.00±0.56	25 (Fluconazole)